BlackRock Investment Management, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2016$11,000
-8.3%
1,3110.0%0.00%
Q3 2016$12,000
+33.3%
1,311
+22.2%
0.00%
Q2 2016$9,000
+80.0%
1,073
+29.9%
0.00%
Q1 2016$5,000
-28.6%
8260.0%0.00%
Q4 2015$7,000
-22.2%
826
+10.6%
0.00%
Q3 2015$9,000
-10.0%
7470.0%0.00%
Q2 2015$10,000
+66.7%
747
+11.2%
0.00%
Q1 2015$6,000
+200.0%
672
-14.5%
0.00%
Q4 2014$2,0000.0%7860.0%0.00%
Q3 2014$2,000
-66.7%
7860.0%0.00%
Q2 2014$6,0007860.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders